Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition is a research paper published in Brain (2021). On theSindex it has a DataRank of 0. It has been cited 81 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National MS Society
Grant: TA-1503-03465
NIBIB NIH HHS
Grant: P41 EB017183
NINDS NIH HHS
Grant: R01 NS041435
Multiple Sclerosis Society
Grant: 10.1
American Academy of Neurology
John F Kurtzke Clinician Scientist Development Award
NIH
EMD-Serono
FWCI
9.53
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination
Additional file 1 of Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination
Additional file 1 of BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions
Additional file 1 of BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions
Additional file 2 of Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination
Additional file 2 of Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination